Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells
Wedel, Steffen, Hudak, Lukasz, Seibel, Jens-Michael, Makarević, Jasmina, Juengel, Eva, Tsaur, Igor, Wiesner, Christoph, Haferkamp, Axel, Blaheta, Roman A.
Published in Clinical & experimental metastasis (01.06.2011)
Published in Clinical & experimental metastasis (01.06.2011)
Get full text
Journal Article
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis
Wedel, Steffen, Hudak, Lukasz, Seibel, Jens-Michael, Makarević, Jasmina, Juengel, Eva, Tsaur, Igor, Waaga-Gasser, Ana, Haferkamp, Axel, Blaheta, Roman A
Published in BMC cancer (25.08.2011)
Published in BMC cancer (25.08.2011)
Get full text
Journal Article
CXC chemokine mRNA expression as a potential diagnostic tool in prostate cancer
Wedel, Steffen A, Raditchev, Ivaylo N, Jones, Jon, Juengel, Eva, Engl, Tobias, Jonas, Dietger, Blaheta, Roman A
Published in Molecular medicine reports (01.03.2008)
Published in Molecular medicine reports (01.03.2008)
Get full text
Journal Article
Steroid‐hormone receptors in cell lines and tumor biopsies of human lung cancer
Kaiser, Ulrich, Hofmann, Jürgen, Schilli, Margret, Wegmann, Bärbel, Klotz, Uwe, Wedel, Steffen, Virmani, Arvind K., Wollmer, Ellen, Branscheid, Detlev, Gazdar, Adi F., Havemann, Klaus
Published in International journal of cancer (29.07.1996)
Published in International journal of cancer (29.07.1996)
Get full text
Journal Article
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Kübler, Hubert, Scheel, Birgit, Gnad-Vogt, Ulrike, Miller, Kurt, Schultze-Seemann, Wolfgang, Vom Dorp, Frank, Parmiani, Giorgio, Hampel, Christian, Wedel, Steffen, Trojan, Lutz, Jocham, Dieter, Maurer, Tobias, Rippin, Gerd, Fotin-Mleczek, Mariola, von der Mülbe, Florian, Probst, Jochen, Hoerr, Ingmar, Kallen, Karl-Josef, Lander, Thomas, Stenzl, Arnulf
Published in Journal for immunotherapy of cancer (16.06.2015)
Published in Journal for immunotherapy of cancer (16.06.2015)
Get full text
Journal Article
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial
Parker, Christopher C., Coleman, Robert E., Sartor, Oliver, Vogelzang, Nicholas J., Bottomley, David, Heinrich, Daniel, Helle, Svein I., O'Sullivan, Joe M., Fosså, Sophie D., Chodacki, Aleš, Wiechno, Paweł, Logue, John, Seke, Mihalj, Widmark, Anders, Johannessen, Dag Clement, Hoskin, Peter, James, Nicholas D., Solberg, Arne, Syndikus, Isabel, Kliment, Jan, Wedel, Steffen, Boehmer, Sibylle, Dall’Oglio, Marcos, Franzén, Lars, Bruland, Øyvind S., Petrenciuc, Oana, Staudacher, Karin, Li, Rui, Nilsson, Sten
Published in European urology (01.03.2018)
Published in European urology (01.03.2018)
Get full text
Journal Article
A Randomised Phase 2 Study Combining LY2181308 Sodium (Survivin Antisense Oligonucleotide) with First-line Docetaxel/Prednisone in Patients with Castration-resistant Prostate Cancer
Wiechno, Paweł, Somer, Bradley G, Mellado, Begoña, Chłosta, Piotr L, Cervera Grau, José Manuel, Castellano, Daniel, Reuter, Christoph, Stöckle, Michael, Kamradt, Jörn, Pikiel, Joanna, Durán, Ignacio, Wedel, Steffen, Callies, Sophie, André, Valérie, Hurt, Karla, Brown, Jacqueline, Lahn, Michael, Heinrich, Bernhard
Published in European urology (01.03.2014)
Published in European urology (01.03.2014)
Get full text
Journal Article
Intermittent vs continuous docetaxel therapy in patients with metastatic castration‐resistant prostate cancer – a phase III study (PRINCE)
Cash, Hannes, Steiner, Ursula, Heidenreich, Axel, Klotz, Theodor, Albers, Peter, Melchior, Sebastian, Martus, Peter, Fuller, Florian, Magheli, Ahmed, Hinz, Stefan, Kempkensteffen, Carsten, Miller, Kurt, Wülfing, Christian, Rudolph, Robert, Müller, Stefan, Stöckle, Michael, Hegele, Axel, Schönfelder, Robert, Manseck, Andreas, Hautmann, Stefan, Schön, Georg, Schulze, Matthias, Gromoll‐Bergmann, Katrin, Simson, Gabriele, Werner, Thorsten, Solga, Matthias, Langhorst, Wolfgang, Wedel, Steffen, Haessner, Joachim, Schröder, Jörg
Published in BJU international (01.11.2018)
Published in BJU international (01.11.2018)
Get full text
Journal Article
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Jones, Jon, Juengel, Eva, Mickuckyte, Ausra, Hudak, Lukasz, Wedel, Steffen, Jonas, Dietger, Blaheta, Roman A.
Published in Journal of cellular and molecular medicine (01.08.2009)
Published in Journal of cellular and molecular medicine (01.08.2009)
Get full text
Journal Article
Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion
Hudak, Lukasz, Tezeeh, Patrick, Wedel, Steffen, Makarević, Jasmina, Juengel, Eva, Tsaur, Igor, Bartsch, Georg, Wiesner, Christoph, Haferkamp, Axel, Blaheta, Roman A.
Published in The Prostate (01.12.2012)
Published in The Prostate (01.12.2012)
Get full text
Journal Article
Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001
Wedel, Steffen, Hudak, Lukasz, Seibel, Jens-Michael, Juengel, Eva, Tsaur, Igor, Wiesner, Christoph, Haferkamp, Axel, Blaheta, Roman A.
Published in Life sciences (1973) (28.02.2011)
Published in Life sciences (1973) (28.02.2011)
Get full text
Journal Article
L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells
DOBERSTEIN, Kai, WIELAND, Anja, BOYOUNG LEE, Sophia B, BLAHETA, Roman A. Alexander, WEDEL, Steffen, MOCH, Holger, SCHRAML, Peter, PFEILSCHIFTER, Josef, KRISTIANSEN, Glen, GUTWEIN, Paul
Published in Carcinogenesis (New York) (01.03.2011)
Published in Carcinogenesis (New York) (01.03.2011)
Get full text
Journal Article
784 OVERCOMING RAD001 TRIGGERED RESISTANCE IN PROSTATE CANCER CDK1-CYCLIN B COMPLEX
Tsaur, Igor, Makarevic, Jasmina, Reiter, Michael, Kurosch, Martin, Bartsch, Georg, Wiesner, Christoph, Wedel, Steffen, Haferkamp, Axel, Blaheta, Roman
Published in The Journal of urology (01.04.2012)
Published in The Journal of urology (01.04.2012)
Get full text
Journal Article
783 THE EFFECTS OF HDAC-INHIBITION ON TUMOR GROWTH AND INTEGRIN DRIVEN INVASION PROCESSES ARE AUGMENTED BY LOW DOSED INTERFERON ALPHA IN PROSTATE CANCER MODELS IN VITRO AND IN VIVO
Wedel, Steffen, Hudak, Lukasz, Tsaur, Igor, Makarevic, Jasmina, Seibel, Jens-Michael, Juengel, Eva, Haferkamp, Axel, Blaheta, Roman
Published in The Journal of urology (01.04.2012)
Published in The Journal of urology (01.04.2012)
Get full text
Journal Article
Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells
Wedel, Steffen, Hudak, Lukasz, Seibel, Jens-Michael, Juengel, Eva, Tsaur, Igor, Haferkamp, Axel, Blaheta, Roman A
Published in Cancer letters (01.02.2011)
Published in Cancer letters (01.02.2011)
Get full text
Journal Article
Prostatakarzinom – Androgenentzug: intermittierend oder kontinuierlich?
Published in Aktuelle Urologie
(01.05.2014)
Get full text
Journal Article
Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer
Wedel, Steffen, Hudak, Lukasz, Seibel, Jens-Michael, Juengel, Eva, Oppermann, Elsie, Haferkamp, Axel, Blaheta, Roman A.
Published in The Prostate (15.05.2011)
Published in The Prostate (15.05.2011)
Get full text
Journal Article